1. The effects of teriparatide on acceleration of bone healing following atypical femoral fracture: comparison between daily and weekly administration
- Author
-
Yuji Kasukawa, Masazumi Suzuki, Hiroyuki Tsuchie, Masaaki Takeshima, T Dohke, Ima Kosukegawa, Koji Nozaka, K Ouchi, Toshihiko Yamashita, Toyohito Segawa, Naohisa Miyakoshi, Yoichi Shimada, Shigeto Maekawa, Takenori Tomite, Toshiaki Aizawa, Kousuke Iba, H Abe, and Hidehumi Kinoshita
- Subjects
Male ,medicine.medical_specialty ,Endocrinology, Diabetes and Metabolism ,medicine.medical_treatment ,Injections, Subcutaneous ,Osteoporosis ,030209 endocrinology & metabolism ,Bone healing ,Drug Administration Schedule ,03 medical and health sciences ,Fracture Fixation, Internal ,0302 clinical medicine ,Atypical femoral fracture ,Internal medicine ,Teriparatide ,Medicine ,Humans ,Aged ,Retrospective Studies ,Aged, 80 and over ,Fracture Healing ,030222 orthopedics ,Bone Density Conservation Agents ,business.industry ,Bisphosphonate ,Middle Aged ,medicine.disease ,Combined Modality Therapy ,Rheumatology ,Surgery ,Denosumab ,Orthopedic surgery ,Female ,business ,Femoral Fractures ,Osteoporotic Fractures ,medicine.drug - Abstract
We compared the effectiveness of promoting bone healing between two teriparatide preparations for atypical femoral fracture (AFF). A total of 45 AFFs were included in this study, and we compared the duration of bone union. Teriparatide administered by daily injection enhanced bone union more than weekly administration in complete AFFs. The efficacy of teriparatide for atypical femoral fracture (AFF) has been recently reported. Although two different teriparatide preparations can be used to treat osteoporosis in Japan, daily or weekly injection, all previous reports on the effectiveness of teriparatide for AFF only examined daily injection formulations. Therefore, we compared the promotion of bone healing between the two teriparatide preparations for AFF. A total of 45 consecutive AFFs in 43 Japanese patients were included in this study. They received either a daily 20-μg teriparatide injection (daily group; n = 32) or a once-a-week 56.5-μg teriparatide injection (weekly group; n = 13). We compared the clinical background and duration of bone union between these two groups. When all patents were included, the fracture healing time was not significantly different between the two groups. Only patients with complete AFFs had significantly fewer daily bisphosphonate or denosumab injections than the weekly group (P
- Published
- 2018